1. PrescQIPP.Bulletin 108: Melatonin.2015. Accessed February 2 2021.https://www.prescqipp.info/umbraco/surface/authorisedmediasurface/index?url=%2fmedia%2f1464%2fb108‐melatonin‐spot‐list‐21.pdf
2. NHS Digital.Prescription Cost Analysis. Accessed February 2 2021.https://digital.nhs.uk/data-and-information/publications/statistical/prescription-cost-analysis
3. PrescQIPP.Bulletin 245: Melatonin.2020. Accessed February 2 2021.https://www.prescqipp.info/umbraco/surface/authorisedmediasurface/index?url=%2fmedia%2f4920%2f245‐melatonin‐22.pdf
4. The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective;Pottegård A;Eur J Clin Pharmacol,2013
5. Paediatric off‐label use of melatonin‐‐a register linkage study between the Norwegian prescription database and patient register;Hartz I;Basic Clin Pharmacol Toxicol,2015